| 內部人士股份 | 2,821,500 shares |
內部人士情緒分數
「內部人士情緒分數」用於查找被公司內部人士購入的公司。
它是一個複雜的多因素量化模型的結果，該模型能夠辨識具有最高內部人士累積持有水平的公司。該評分模型結合了內部人士在過去90天內購買的淨數量、總購買股份佔流通股比例，以及內部人士擁有的總股份的指標。該分數的範圍從0到100，數值越高表示相對於同行業而言具有更高程度的內部人士持股水平，50為平均值。
更新頻率：每日
高管情緒分數
「高管情緒分數」用於查找被公司管理層購入的公司。
根據定義，公司高管是公司內部人士，但與其他內部人士（10%的股東和董事會成員）不同，公司高管每天在公司工作，而且他們使用自己的資金進行交易。（10%的股東和董事會成員通常是基金經理，管理著其他人的資金。）因此，公司高管進行的內幕交易更為重要性，應該被適當地重視和關注。
如同「內部人士情緒分數」，「高管情緒分數」也是一個複雜的多因素量化模型的計算結果，該模型能夠辨識具有最高高管累積持有水平的公司。
更新頻率：每日
關鍵內部人士指標
此表格顯示了公司在各種內部人士指標上的排名。百分位數排名顯示了這家公司在美國市場與其他公司相比的表現。排名越高表明公司所處狀況越好。
舉例來說，一般認為內部人士的買入是一個積極的指標，因此具有更多內部人士買入的公司將排名高於那些內部人士買入較少（甚至有內部人士賣出）的公司。
內部人士買入淨數（排名）
N/A
內部人士買入淨數是過去90天內買入的內部人士總數減去賣出的內部人士總數。以百分位排名顯示（範圍從0到100%）。
內部人士買入佔流通股比例（排名）
N/A
內部人士買入佔流通股比例是內部人士在過去90天內購買的股份總數減去賣出的股份總數，除以總流通股數並乘以100。
內幕交易圖表
以下圖表顯示了CM Life Sciences III Inc - Units (1 Ord Class A & 1/5 War)內部人士交易。內部人士包括公司的高管、董事或重要投資者。一般而言，基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是，他們必須透過Form 4向美國證券交易委員會（SEC）報告所有交易。
內部人員名單及盈利指標
這張表格顯示已知的內部人員名單，從向SEC披露的申報文件中自動生成。除了姓名、最近的職稱和董事、高管或10%擁有人的標誌外，我們還提供了最新披露的持股信息。此外，我們盡可能提供內部人的歷史交易表現。歷史交易表現是內部人士實際進行的公開市場購買交易表現的加權平均值。有關此計算方式的更多資訊，請查看YouTube網絡研討會。
See our leaderboard of most profitable insider traders.
| 內部人士 | 平均收益（%） | 持股 數量 |
分拆 調整 |
|---|
Report errors via our new Insider Auditing Tool
追蹤內部人士買入記錄 - 短期收益分析
在這一部分，我們分析了在 CMLTU / CM Life Sciences III Inc - Units (1 Ord Class A & 1/5 War) 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況， 結果僅為理論值。 .
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
| 交易日期 | 內部人士 | 報告 股數 |
報告 價格 |
經調整 股數 |
經調整 價格 |
成本基礎 | 達到最高利潤的 天數 |
達到最高利潤時的 價格 |
最高 淨利 ($) |
最高回報率（%） |
|---|---|---|---|---|---|---|---|
| 當前未知該內部人士進行過任何未預先計劃的公開市場交易。 |
經調整價格 已按拆股調整。 經調整股數 已按拆股調整。
追蹤內部人士賣出記錄 - 短期虧損分析
在這一部分，我們分析了在 CMLTU / CM Life Sciences III Inc - Units (1 Ord Class A & 1/5 War) 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況， 結果僅為理論值。 .
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
| 交易日期 | 內部人士 | 報告 股數 |
報告 價格 |
經調整 股數 |
經調整 價格 |
成本基礎 | 達到最低利潤的 天數 |
達到最低利潤時的 價格 |
避免的 最高損失金額($) |
避免的 最高損失率($) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-01 | CMLS Holdings III LLC | 200,000 | 0.0020 | 200,000 | 0.0020 | 400 | 138 | 8.69 | 1,737,600 | 434,400.00 |
經調整價格 已按拆股調整。 經調整股數 已按拆股調整。
交易歷史
點擊連結圖示即可查看完整的交易記錄。作為 10b5-1 自動交易計畫的一部分進行報告的交易，將在標記為 10b-5 的欄位中顯示 X。
| 呈報 日期 |
交易 日期 |
表格 | 內部人士 | 證券代碼 | 證券種類 | 代碼 | 直接 | 行使 價格 |
單位 價格 |
股數 變化 |
價值 變化 (1K) |
剩餘 期權 |
剩餘 股份 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-14 | 2023-11-09 | 4 | Casdin Eli | EQRX | Common Stock | I | -5,488,164 | 0 | ||||||
| 2023-11-14 | 2023-11-09 | 4 | Casdin Eli | EQRX | Common Stock | I | -3,824,572 | 0 | ||||||
| 2023-11-14 | 2023-11-09 | 4 | Casdin Eli | EQRX | Common Stock | I | -30,214,934 | 0 | ||||||
| 2023-11-14 | 2023-11-09 | 4 | Casdin Eli | EQRX | Common Stock | I | -8,659,372 | 0 | ||||||
| 2023-11-09 | 2023-11-09 | 4 | AH Equity Partners Bio II, L.L.C. By Andreessen Horowitz LSV Fund II, L.P. | EQRX | Common Stock | I | -5,000,000 | 0 | ||||||
| 2023-11-09 | 2023-11-09 | 4 | AH Equity Partners Bio II, L.L.C. By Andreessen Horowitz LSV Fund I, L.P. | EQRX | Common Stock | I | -11,433,677 | 0 | ||||||
| 2023-11-09 | 2023-11-09 | 4 | AH Equity Partners Bio II, L.L.C. By AH Bio Fund III, L.P. | EQRX | Common Stock | I | -19,192,015 | 0 | ||||||
| 2023-11-09 | 2023-11-09 | 4 | AH Equity Partners Bio II, L.L.C. By AH Bio Fund II, L.P. | EQRX | Common Stock | I | -17,438,465 | 0 | ||||||
| 2023-11-09 | 2023-11-09 | 4 | AH Equity Partners Bio II, L.L.C. By AD Holdings, LLC | EQRX | Common Stock | I | -12,264 | 0 | ||||||
| 2023-11-09 | 2023-11-09 | 4 | Abernethy Amy | EQRX | Common Stock | D | -200,000 | 0 | ||||||
| 2023-11-09 | 2023-11-09 | 4 | Borisy Alexis | EQRX | Common Stock | D | -18,810,000 | 0 | ||||||
| 2023-11-09 | 2023-11-09 | 4 | AH Equity Partners LSV I, L.L.C. By Andreessen Horowitz LSV Fund II, L.P. | EQRX | Common Stock | I | -5,000,000 | 0 | ||||||
| 2023-11-09 | 2023-11-09 | 4 | AH Equity Partners LSV I, L.L.C. By Andreessen Horowitz LSV Fund I, L.P. | EQRX | Common Stock | I | -11,433,677 | 0 | ||||||
| 2023-11-09 | 2023-11-09 | 4 | AH Equity Partners LSV I, L.L.C. By AH Bio Fund III, L.P. | EQRX | Common Stock | I | -19,192,015 | 0 | ||||||
| 2023-11-09 | 2023-11-09 | 4 | AH Equity Partners LSV I, L.L.C. By AH Bio Fund II, L.P. | EQRX | Common Stock | I | -17,438,465 | 0 | ||||||
| 2023-11-09 | 2023-11-09 | 4 | AH Equity Partners LSV I, L.L.C. By AD Holdings, LLC | EQRX | Common Stock | I | -12,264 | 0 | ||||||
| 2023-11-09 | 2023-11-09 | 4 | Conde Jorge By Andreessen Horowitz LSV Fund II, L.P. | EQRX | Common Stock | I | -5,000,000 | 0 | ||||||
| 2023-11-09 | 2023-11-09 | 4 | Conde Jorge By Andreessen Horowitz LSV Fund I, L.P. | EQRX | Common Stock | I | -11,433,677 | 0 | ||||||
| 2023-11-09 | 2023-11-09 | 4 | Conde Jorge By AH Bio Fund III, L.P. | EQRX | Common Stock | I | -19,192,015 | 0 | ||||||
| 2023-11-09 | 2023-11-09 | 4 | Conde Jorge By AH Bio Fund II, L.P. | EQRX | Common Stock | I | -17,438,465 | 0 | ||||||
| 2023-11-09 | 2023-11-09 | 4 | Ciarimboli Dina | EQRX | Common Stock | D | -731,750 | 0 | ||||||
| 2023-11-09 | 2023-11-09 | 4 | Horning Sandra | EQRX | Common Stock | D | -470,250 | 0 | ||||||
| 2023-11-09 | 2023-11-09 | 4 | BERNS PAUL L | EQRX | Common Stock | D | -627,000 | 0 | ||||||
| 2023-11-09 | 2023-11-09 | 4 | Nallicheri Melanie By MIN 2020 LLC | EQRX | Common Stock | I | -3,851,147 | 0 | ||||||
| 2023-11-09 | 2023-11-09 | 4 | Nallicheri Melanie | EQRX | Common Stock | D | -6,306,246 | 0 | ||||||
| 2023-11-09 | 2023-11-09 | 4 | Nallicheri Melanie | EQRX | Common Stock | D | 2.2100 | 626,999 | 1,386 | 6,306,246 | ||||
| 2023-07-03 | 2023-07-01 | 4 | Ciarimboli Dina | EQRX | Common Stock | D | 575,000 | 731,750 | ||||||
| 2022-03-01 | 2022-02-25 | 4 | Nallicheri Melanie | EQRX | Stock Option (Right to Buy) | D | 3.03 | 1,900,000 | 1,900,000 | |||||
| 2022-03-01 | 2022-02-25 | 4 | Abernethy Amy | EQRX | Stock Option (Right to Buy) | D | 3.03 | 449,644 | 449,644 | |||||
| 2022-03-01 | 2022-02-25 | 4 | Rubin Jami | EQRX | Stock Option (Right to Buy) | D | 3.03 | 515,601 | 515,601 | |||||
| 2022-03-01 | 2022-02-25 | 4 | Ciarimboli Dina | EQRX | Stock Option (Right to Buy) | D | 3.03 | 575,000 | 575,000 | |||||
| 2022-03-01 | 3 | Ciarimboli Dina | EQRX | Common Stock | D | 156,750 | ||||||||
| 2022-03-01 | 2022-02-25 | 4 | Hedrick Eric | EQRX | Stock Option (Right to Buy) | D | 3.03 | 505,051 | 505,051 | |||||
| 2021-12-23 | 2021-12-17 | 4/A | Casdin Eli By CMLS Holdings III LLC | EQRX | Warrants to purchase Class A Common Stock (right to buy) | I | 11.50 | 8,110,001 | 8,110,001 | |||||
| 2021-12-23 | 2021-12-17 | 4/A | Casdin Eli By Casdin Private Growth Equity Fund, L.P. | EQRX | Earn-out Shares | I | 751,807 | 751,807 | ||||||
| 2021-12-23 | 2021-12-17 | 4/A | Casdin Eli By Casdin Venture Opportunities Fund, L.P. | EQRX | Earn-out Shares | I | 523,916 | 523,916 | ||||||
| 2021-12-23 | 2021-12-17 | 4/A | Casdin Eli By Casdin Partners Master Fund L.P. | EQRX | Earn-out Shares | I | 3,454,116 | 3,454,116 | ||||||
| 2021-12-23 | 2021-12-17 | 4/A | Casdin Eli By CMLS Holdings III LLC | EQRX | Class B Common Stock | I | -8,659,372 | 0 | ||||||
| 2021-12-23 | 2021-12-17 | 4/A | Casdin Eli By CMLS Holdings III LLC | EQRX | Class B Common Stock | I | -4,840,628 | 8,659,372 | ||||||
| 2021-12-23 | 2021-12-17 | 4/A | Casdin Eli By Casdin Private Growth Equity Fund, L.P. | EQRX | Common Stock | I | 5,488,164 | 5,488,164 | ||||||
| 2021-12-23 | 2021-12-17 | 4/A | Casdin Eli By Casdin Venture Opportunities Fund, L.P. | EQRX | Common Stock | I | 3,824,572 | 3,824,572 | ||||||
| 2021-12-23 | 2021-12-17 | 4/A | Casdin Eli By Casdin Partners Master Fund L.P. | EQRX | Common Stock | I | 10.0000 | 5,000,000 | 50,000 | 30,214,934 | ||||
| 2021-12-23 | 2021-12-17 | 4/A | Casdin Eli By Casdin Partners Master Fund L.P. | EQRX | Common Stock | I | 25,214,934 | 25,214,934 | ||||||
| 2021-12-23 | 2021-12-17 | 4/A | Casdin Eli By CMLS Holdings III LLC | EQRX | Common Stock | I | 8,659,372 | 8,659,372 | ||||||
| 2021-12-23 | 2021-12-17 | 4/A | Casdin Eli By CMLS Holdings III LLC | EQRX | Class A Common Stock | I | -8,659,372 | 0 | ||||||
| 2021-12-23 | 2021-12-17 | 4/A | Casdin Eli By CMLS Holdings III LLC | EQRX | Class A Common Stock | I | 8,659,372 | 8,659,372 | ||||||
| 2021-12-22 | 3 | HOROWITZ BENJAMIN A By AH Bio Fund III, L.P. | EQRX | Common Stock | I | 19,192,015 | ||||||||
| 2021-12-22 | 3 | HOROWITZ BENJAMIN A By AH Bio Fund II, L.P. | EQRX | Common Stock | I | 17,438,465 | ||||||||
| 2021-12-22 | 3 | HOROWITZ BENJAMIN A By Andreessen Horowitz LSV Fund I, L.P. | EQRX | Common Stock | I | 11,433,677 | ||||||||
| 2021-12-22 | 3 | HOROWITZ BENJAMIN A By Andreessen Horowitz LSV Fund II, L.P. | EQRX | Common Stock | I | 5,000,000 | ||||||||
| 2021-12-22 | 3 | AH Bio Fund III-Q, L.P. By AH Bio Fund II, L.P. | EQRX | Common Stock | I | 17,438,465 | ||||||||
| 2021-12-22 | 3 | AH Bio Fund III-Q, L.P. By Andreessen Horowitz LSV Fund II, L.P. | EQRX | Common Stock | I | 5,000,000 | ||||||||
| 2021-12-22 | 3 | AH Bio Fund III-Q, L.P. By AH Bio Fund III, L.P. | EQRX | Common Stock | I | 19,192,015 | ||||||||
| 2021-12-22 | 3 | AH Bio Fund III-Q, L.P. By Andreessen Horowitz LSV Fund I, L.P. | EQRX | Common Stock | I | 11,433,677 | ||||||||
| 2021-12-21 | 2021-12-17 | 4 | Conde Jorge By Andreessen Horowitz LSV Fund I, L.P. | EQRX | Earn-out Shares | I | 1,566,264 | 1,566,264 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | Conde Jorge By AH Bio Fund III, L.P. | EQRX | Earn-out Shares | I | 2,629,055 | 2,629,055 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | Conde Jorge By AH Bio Fund II, L.P. | EQRX | Earn-out Shares | I | 2,388,841 | 2,388,841 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | Conde Jorge By Andreessen Horowitz LSV Fund II, L.P. | EQRX | Common Stock | I | 10.0000 | 5,000,000 | 50,000 | 5,000,000 | ||||
| 2021-12-21 | 2021-12-17 | 4 | Conde Jorge By Andreessen Horowitz LSV Fund I, L.P. | EQRX | Common Stock | I | 11,433,677 | 11,433,677 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | Conde Jorge By AH Bio Fund III, L.P. | EQRX | Common Stock | I | 19,192,015 | 19,192,015 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | Conde Jorge By AH Bio Fund II, L.P. | EQRX | Common Stock | I | 17,438,465 | 17,438,465 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | Casdin Eli By CMLS Holdings III LLC | EQRX | Warrants to purchase Class A Common Stock (right to buy) | I | 11.50 | 8,110,001 | 8,110,001 | |||||
| 2021-12-21 | 2021-12-17 | 4 | Casdin Eli By CMLS Holdings III LLC | EQRX | Class B Common Stock | I | -8,659,372 | 0 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | Casdin Eli By CMLS Holdings III LLC | EQRX | Class B Common Stock | I | -4,840,628 | 0 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | Casdin Eli Casdin Partners Master Fund, L.P. | EQRX | Common Stock | I | 10.0000 | 5,000,000 | 50,000 | 48,187,043 | ||||
| 2021-12-21 | 2021-12-17 | 4 | Casdin Eli Casdin Partners Master Fund, L.P. | EQRX | Common Stock | I | 34,527,671 | 43,187,043 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | Casdin Eli By CMLS Holdings III LLC | EQRX | Common Stock | I | 8,659,372 | 8,659,372 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | BERNS PAUL L | EQRX | Earn-out Shares | D | 85,891 | 85,891 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | BERNS PAUL L | EQRX | Common Stock | D | 627,000 | 627,000 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | Abernethy Amy | EQRX | Class B Common Stock | D | -200,000 | 0 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | Abernethy Amy | EQRX | Common Stock | D | 200,000 | 200,000 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | Abernethy Amy | EQRX | Class A Common Stock | D | -200,000 | 0 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | Abernethy Amy | EQRX | Class A Common Stock | D | 200,000 | 200,000 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | Hedrick Eric | EQRX | Earn-out Shares | D | 103,069 | 103,069 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | Hedrick Eric | EQRX | Stock Option (Right to Buy) | D | 2.21 | 125,399 | 125,399 | |||||
| 2021-12-21 | 2021-12-17 | 4 | Hedrick Eric | EQRX | Common Stock | D | 627,000 | 627,000 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | Horning Sandra | EQRX | Earn-out Shares | D | 107,364 | 107,364 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | Horning Sandra | EQRX | Stock Option (Right to Buy) | D | 0.44 | 313,500 | 313,500 | |||||
| 2021-12-21 | 2021-12-17 | 4 | Horning Sandra | EQRX | Common Stock | D | 470,250 | 470,250 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | Borisy Alexis | EQRX | Earn-out Shares | D | 2,877,343 | 2,877,343 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | Borisy Alexis | EQRX | Stock Option (Right to Buy) | D | 2.68 | 2,194,499 | 2,194,499 | |||||
| 2021-12-21 | 2021-12-17 | 4 | Borisy Alexis | EQRX | Common Stock | D | 18,810,000 | 18,810,000 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | GIUSTI KATHRYN E | EQRX | Earn-out Shares | D | 21,820 | 21,820 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | GIUSTI KATHRYN E | EQRX | Stock Option (Right to Buy) | D | 8.84 | 159,286 | 159,286 | |||||
| 2021-12-21 | 2021-12-17 | 4 | Nallicheri Melanie By MIN 2020 LLC | EQRX | Earn-out Shares | I | 527,558 | 527,558 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | Nallicheri Melanie | EQRX | Earn-out Shares | D | 1,035,655 | 1,035,655 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | Nallicheri Melanie | EQRX | Stock Option (Right to Buy) | D | 2.68 | 1,253,999 | 1,253,999 | |||||
| 2021-12-21 | 2021-12-17 | 4 | Nallicheri Melanie | EQRX | Stock Option (Right to Buy) | D | 2.21 | 626,999 | 626,999 | |||||
| 2021-12-21 | 2021-12-17 | 4 | Nallicheri Melanie By MIN 2020 LLC | EQRX | Common Stock | I | 3,851,147 | 3,851,147 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | Nallicheri Melanie | EQRX | Common Stock | D | 5,679,247 | 5,679,247 | ||||||
| 2021-12-20 | 2021-12-17 | 4 | Rubin Jami | EQRX | Earn-out Shares | D | 300,618 | 300,618 | ||||||
| 2021-12-20 | 2021-12-17 | 4 | Rubin Jami | EQRX | Common Stock | D | 2,194,500 | 2,194,500 | ||||||
| 2021-12-20 | 2021-12-17 | 4 | MEANWELL CLIVE | EQRX | Earn-out Shares | D | 42,946 | 42,946 | ||||||
| 2021-12-20 | 2021-12-17 | 4 | MEANWELL CLIVE | EQRX | Stock Option (Right to Buy) | D | 0.44 | 313,500 | 313,500 | |||||
| 2021-08-03 | 2021-08-01 | 4 | CMLS Holdings III LLC | CMLT | Class B common stock | I | 0.0020 | -200,000 | -0 | 13,500,000 |
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券（例如股票期權）
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券（例如期權）
V
內部人士透過Form 4自願報告的一筆交易
J
其他（附有交易描述的腳註）
